MultiPlan Corporation MPLN
Set alert
At close · Feb 27
52-week range unavailable
- YTD
- +56.63%
- 1 year
- -29.42%
- Open
- 23.99
- Prev close
- 23.15
- Mkt cap
- 101.56M
- Vol
- 204.84K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 22.77
- High
- 24.99
- Forward P/E
- -0.72
- Beta
- 0.64
- Short ratio
- 4.50
- Inst. own
- 81.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 8.27
- 200-d avg
- 16.11
- 1y target
- 10.00
2Y chart
Events in this range
- Mar 8, 2023Rating: Citigroup · — → Neutral
- Feb 29, 2024Earnings: -2.4; estimate 0; surprise —%
- May 8, 2024Earnings: -1.2; estimate 0; surprise —%
- May 8, 2024Earnings: —; estimate 0; surprise —%
- Jun 26, 2024Rating: Piper Sandler · — → Neutral
- Aug 1, 2024Earnings: -1.2; estimate -1.6; surprise 25%
- Aug 1, 2024Earnings: —; estimate -1.6; surprise —%
- Aug 7, 2024Rating: Piper Sandler · Neutral → Neutral
- Sep 23, 2024Split: 1 for 40
- Sep 23, 2024Rating: Citigroup · Neutral → Neutral
- Nov 5, 2024Earnings: -1.85; estimate -2.37; surprise 21.94%
Signals (74)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Feb 25, 2025 | 1 year ago |
| RSI: Overbought | Feb 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 30, 2025 | 1 year ago |
| RSI: Overbought | Jan 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 29, 2025 | 1 year ago |
| SMA: Bullish | Jan 14, 2025 | 1 year ago |
| SMA: Bearish | Dec 30, 2024 | 1 year ago |
| SMA: Bullish | Dec 27, 2024 | 1 year ago |
| SMA: Bullish | Dec 24, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 24, 2024 | 1 year ago |
| RSI: Overbought | Dec 24, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 20, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 27, 2024 | 1 year ago |
| RSI: Oversold | Nov 15, 2024 | 1 year ago |
| SMA: Bearish | Oct 30, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 25, 2024 | 2 years ago |
| SMA: Bullish | Oct 8, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 1, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 24, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 23, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 2, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 25, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 10, 2024 | 2 years ago |
| RSI: Oversold | Jul 3, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 2, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 26, 2024 | 2 years ago |
| MACD: Sell Signal | May 31, 2024 | 2 years ago |
| MACD: Buy Signal | May 22, 2024 | 2 years ago |
| MACD: Sell Signal | May 20, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| RSI: Oversold | Apr 22, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 18, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 22, 2024 | 2 years ago |
| RSI: Oversold | Mar 11, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 5, 2024 | 2 years ago |
| SMA: Bearish | Feb 16, 2024 | 2 years ago |
| SMA: Bullish | Feb 15, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 2, 2024 | 2 years ago |
| RSI: Oversold | Jan 23, 2024 | 2 years ago |
| RSI: Oversold | Jan 18, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 2, 2024 | 2 years ago |
| SMA: Bearish | Dec 29, 2023 | 2 years ago |
| SMA: Bearish | Dec 29, 2023 | 2 years ago |
| RSI: Overbought | Dec 21, 2023 | 2 years ago |
| SMA: Bullish | Dec 14, 2023 | 2 years ago |
| SMA: Bullish | Dec 14, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 29, 2023 | 2 years ago |
| RSI: Oversold | Nov 9, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 6, 2023 | 2 years ago |
| SMA: Bearish | Oct 31, 2023 | 3 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 27, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 25, 2023 | 3 years ago |
| SMA: Bullish | Oct 24, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 20, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 6, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 28, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 20, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Sep 7, 2023 | 3 years ago |
| SMA: Bullish | Sep 6, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 31, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bullish | Aug 8, 2023 | 3 years ago |
| SMA: Bearish | Aug 4, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 3, 2023 | 3 years ago |
| RSI: Overbought | Jun 14, 2023 | 3 years ago |
| RSI: Overbought | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | May 22, 2023 | 3 years ago |
| SMA: Bearish | May 19, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| MACD: Buy Signal | May 10, 2023 | 3 years ago |
| RSI: Oversold | May 4, 2023 | 3 years ago |
Key statistics
- Market cap
- 101.56M
- Enterprise value
- 4.56B
- Trailing P/E
- 0.00
- Forward P/E
- -0.72
- PEG ratio
- 0.00
- Price / sales
- 0.11
- Price / book
- 0.49
- EPS (TTM)
- -95.28
- Beta
- 0.64
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -163.30%
- Revenue (TTM)
- 942.61M
- Revenue growth
- -5.10%
- Free cash flow
- 231.46M
- Total cash
- 86.92M
- Total debt
- 4.55B
- Return on equity
- -157.30%
- Shares outstanding
- 16.17M
- Short % of float
- 3.54%
- 50-day average
- 8.27
- 200-day average
- 16.11
Analyst view
Consensus: none
- Strong buy1
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Aug 1, 2024
Expected Aug 1, 2024. Consensus EPS estimate -2.33.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2024 | Sep 1, 2024 | -2.37 | -1.85 | +0.52 | +21.94% |
| Aug 1, 2024 | Jun 1, 2024 | -1.60 | -1.20 | +0.40 | +25.00% |
| Aug 1, 2024 | Jun 1, 2024 | -1.60 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.00 | -1.20 | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Feb 29, 2024 | Dec 1, 2023 | 0.00 | -2.40 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2024 | Citigroup | main | Neutral | Neutral |
| Aug 7, 2024 | Piper Sandler | reit | Neutral | Neutral |
| Jun 26, 2024 | Piper Sandler | init | — | Neutral |
| Mar 8, 2023 | Citigroup | main | — | Neutral |
| Jan 18, 2023 | Barclays | main | — | Equal-Weight |
| Dec 13, 2022 | Citigroup | down | Buy | Neutral |
About MultiPlan Corporation
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- multiplan.us
News
- ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks
- Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript
- MultiPlan Corporation (MPLN) Reports Q4 Loss, Misses Revenue Estimates
- Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025
- Earnings Scheduled For February 25, 2025
- Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design
- MultiPlan Enters New Era and Unveils New Brand, Claritev, Reflecting Company's Transformation and Mission to Support the Healthcare Continuum
- MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
- MultiPlan Announces Expiration and Results of Exchange Offers and Consent Solicitations for Outstanding Notes and Term Loans with Over 99% Participation of Existing Noteholders and Lenders
- MultiPlan (MPLN) Soars 15.5%: Is Further Upside Left in the Stock?
Your note
Sign in to keep a note on MPLN — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| H&F Corporate Investors VIII, Ltd. | 33.32% | 5,387,862 | 33.84M | Sep 29, 2024 |
| Public Investment Fund | 7.92% | 1,281,250 | 8.05M | Sep 29, 2024 |
| Leonard Green & Partners, L.P. | 5.94% | 961,249 | 6.04M | Sep 29, 2024 |
| Ares Management LLC | 4.64% | 749,738 | 4.71M | Sep 29, 2024 |
| CPV Partners, LLC | 3.06% | 495,258 | 3.11M | Sep 29, 2024 |
| Beach Point Capital Management LP | 2.18% | 352,400 | 2.21M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.86% | 301,369 | 1.89M | Sep 29, 2024 |
| Price (T.Rowe) Small-Cap Value Fund | 0.79% | 127,501 | 800.71K | Sep 29, 2024 |
| Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 0.64% | 104,021 | 653.25K | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 0.60% | 97,082 | 609.67K | Aug 30, 2024 |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | 0.27% | 43,923 | 275.84K | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.20% | 32,312 | 202.92K | Aug 30, 2024 |